We live at a time when bioprocessing has never been more critical. The demand for next-generation vaccines and therapeutics is heavily outweighing the supply – a situation brought upon by the complexities inherent to disease, and to manufacturing these potential solutions. The speed at which biologics can be manufactured cannot keep up with those in development, thus we are perpetually behind the curve of supplying patients with the best therapeutics. Bioprocessing has seemingly reached a stagnation point, or asymptotic behavior comparable to that predicted by Moore’s Law in the electronics industry. And, as the electronics industry has shattered that “law” multiple times, bioprocessing must also prepare for the next quantum leap in order to meet the unrelenting demand. There are fundamental missing links to realizing Industry 4.0 in bioprocessing – truly easy-to-use and reliable sensors, accessible data and analytics, and flexible integration. Sensors and analytics enable connections between critical process parameters and critical quality attributes, and quality ultimately defines safety, predictability and cost-effectiveness. Nirrin’s mission is thus to design, develop, manufacture high quality sensor and integration technologies by understanding and exceeding the technical needs of our pharmaceutical development customers while providing outstanding customer satisfaction and most competitive and innovative solutions. Our goal is to meet that need and to transform the way that biologics are developed and manufactured